Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| VU0467485；AZ13713945 | C17H17FN4O2S | 1451994-10-7 | Details |
| SHP836 | C16H19Cl2N5 | 1957276-35-5 | Details |
| Nifeviroc；TD0232;TD 0232;TD-0232 | C33H42N4O6 | 934740-33-7 | Details |
| PKR-IN-C51；PKR inhibitor C51;PKRINC51;PKR-inhibitor-C51;PKR IN C51 | C23H21N5 | 1314594-23-4 | Details |
| XX-650-23；XX 650 23;XX65023 | C18H12N2O2 | 117739-40-9 | Details |
| nNOS-IN-25；nNOS IN 25;nNOSIN25;nNOS inhibitor 25;nNOS inhibitor-25 | C21H22N4 | 1895092-16-6 | Details |
| BETi-211 | C26H29N7O3 | 1995867-02-1 | Details |
| HIV-1 Inhibitor 18A；HIV-1 Inhibitor-18A | C14H11N5O2S | 331261-50-8 | Details |
| A-315675；A315675;A 315675 | C17H30N2O4 | 335679-69-1 | Details |
| Relmapirazin | C12H16N6O8 | 1313706-17-0 | Details |
| Nostopeptin B | C46H70N8O12 | 185980-89-6 | Details |
| NPD9948；NPD-9948;NPD 9948 | C13H14N6 | 59856-85-8 | Details |
| SCH-50910 free base；SCH 50910;SCH50910 | C8H15NO3 | 790633-59-9 | Details |
| BZAD01；BZAD-01;BZAD 01 | C16H12F6N2O | 305339-41-7 | Details |
| Mebendazole-amine；G1029;R 18986;R-18986;G-1029;G 1029;R18986 | C14H11N3O | 52329-60-9 | Details |
| Flecainide；Tambocor;Flecainidum;Flecainida;Apocard | C17H20F6N2O3 | 54143-55-4 | Details |
| Droxicam；Droxicamum | C16H11N3O5S | 90101-16-9 | Details |
| 7-Methyladenine；NSC 7857;NSC-7857;NSC7857 | C6H7N5 | 935-69-3 | Details |
| Pirlindole free base；Pirlindole;Pyrazidol | C15H18N2 | 60762-57-4 | Details |
| SL-01；ZLPhe chloromethyl ketone;Z L Phe chloromethyl ketone;NSC-251810;Z-Phe-chloromethylketone | C18H18ClNO3 | 26049-94-5 | Details |
| Desethylamiodarone；LB33020;N-Deethylamiodarone;LB 33020;N-Monodesethylamiodarone;DAMI;LB-33020 | C23H25I2NO3 | 83409-32-9 | Details |
| (-)-Chromanol 293B；(-)-[3R,4S]-Chromanol 293B | C15H20N2O4S | 163163-24-4 | Details |
| Phenol, 4-chloro-5-methyl-2-nitro- | C7H6ClNO3 | 7147-89-9 | Details |
| 1-Phenylpyrrole；NSC 16581;NSC16581;NSC-16581 | C10H9N | 635-90-5 | Details |
| 2-PADQZ；2PADQZ;2 PADQZ;2-PADQZ | C14H19N5O2 | 60547-97-9 | Details |
| Uridine triacetate；RG2133;PN401;RG-2133;PN 401;PN-401;RG 2133 | C15H18N2O9 | 4105-38-8 | Details |
| Olopatadine；Patanol;Opatanol;KW-4943A;KW-4679 | C21H23NO3 | 113806-05-6 | Details |
| Cloransulam-methyl；Cloransulam - methyl;Cloransulam methyl | C15H13ClFN5O5S | 147150-35-4 | Details |
| 5M038 | C17H8F6N4 | 338962-32-6 | Details |
| C.I. 37505；3-Hydroxy-2-naphthanilide;2-Naphthanilide, 3-hydroxy- (8CI) | C17H13NO2 | 92-77-3 | Details |
| UPGL00004 | C25H26N8O2S2 | 1890169-95-5 | Details |
| Bryostatin 3 | C46H64O17 | 143370-84-7 | Details |
| RS 100329 hydrochloride | C20H26ClF3N4O3 | 1215654-26-4 | Details |
| S 14506 hydrochloride | C24H27ClFN3O2 | 286369-38-8 | Details |
| NAS181；NAS-181 | C20H30N2O7S | 1217474-40-2 | Details |
| (S)-(+)-Niguldipine hydrochloride | C36H40ClN3O6 | 113145-69-0 | Details |
| RS-25344 hydrochloride；RS 25344 hydrochloride | C19H14ClN5O4 | 152815-28-6 | Details |
| alphaSYN-IN-NAB2；alphaSYNINNAB2;alphaSYN IN NAB2;alphaSYN inhibitor NAB2;NAB2;alphaSYN inhibitor-NAB2 | C23H20ClN3O | 1504588-00-4 | Details |
| Dodine；Cyprex;Melprex 65;ENT 16,436;Karpen;Syllit 65 | C15H33N3O2 | 2439-10-3 | Details |
| Eugenone；Eugenon;J167.369F | C13H16O5 | 480-27-3 | Details |
| Conjugated Estrogen sodium；Conest;Conjugated estrogens;HSDB 3076;Estrogens, conjugated;Kestrin;TAG-39 | C18H19NaO5S | 12126-59-9 | Details |
| PU3；PU 3;PU-3 | C19H25N5O3 | 352519-21-2 | Details |
| AKI603；AKI-603;AKI 603 | C19H23N9O2 | 1432515-73-5 | Details |
| BCI-137；BCI137;BCI 137 | C11H11N3O6S | 112170-24-8 | Details |
| BRD2492 | C20H18N4O2 | 1821669-43-5 | Details |
| DJ101；DJ-101;DJ 101 | C23H20N4O3 | 1803242-21-8 | Details |
| EG1 | C22H18N2O5 | 693241-54-2 | Details |
| A-7 hydrochloride | C20H29Cl2NO2S | 79127-24-5 | Details |
| Y-27632；Y27632 | C14H21N3O | 146986-50-7 | Details |
| Indoleacetyl phenylalanine；Indol-3 acetyl phenylalanine;Indoleacetyl-phenylalanine;Indoleacetylphenylalanine | C19H18N2O3 | 57105-50-7 | Details |
| RP 67580 | C29H30N2O2 | 135911-02-3 | Details |
| Ro 20-1724；4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;Ro20-1724;Ro-20-1724 | C15H22N2O3 | 29925-17-5 | Details |
| ATP；Adenosine triphosphate;Adenosine triphosphate;Ara-ATP;Atipi;ATP disodium salt hydrate;Ara-ATP;Triphosphaden;Triphosphoric acid adenosine ester | C10H16N5O13P3 | 56-65-5 | Details |
| Ethyl 4-hydroxyphenylacetate | C10H12O3 | 17138-28-2 | Details |
| Nitrophenide | C12H8N2O4S2 | 537-91-7 | Details |
| Dicapthon；Captex;AC-4124;ENT-17035;AC4124;ENT 17035;AC 4124 | C8H9ClNO5PS | 2463-84-5 | Details |
| 3-Nitrophenetole；AI3-15391;AI315391;AI3 15391 | C8H9NO3 | 621-52-3 | Details |
| C.I. 15670；NSC-12453;NSC 12453;NSC12453 | C16H11N2NaO5S | 2092-55-9 | Details |
| TIPP；Tyr-Tic-Phe-Phe-OH | C37H38N4O6 | 146369-65-5 | Details |
| Ertapenem；MK0826;Invanz;MK 0826;MK-0826 | C22H25N3O7S | 153832-46-3 | Details |
| GR 94800 | C49H61N9O8 | 141636-65-9 | Details |
| Diprotin B | C16H29N3O4 | 90614-49-6 | Details |
| HTH-01-091；HTH01-091;HTH-01091;HTH01091;HTH 01091;HTH 01-091 | C26H28Cl2N4O2 | 2000209-42-5 | Details |
| MAC173979；MAC 173979;MAC-173979 | C9H5Cl2NO3 | 41501-64-8 | Details |
| VU0661013 | C39H39Cl2N5O4 | 2131184-57-9 | Details |
| Fosmetpantotenate；RE024;RE 024;RE-024 | C20H31N2O9P | 1858268-66-2 | Details |
| Atiprimod dimaleate；SK&F 106615;SK&F106615;SK&F-106615 | C26H48N2O4 | 183063-72-1 | Details |
| ER819762；ER-819762;ER 819762 | C30H39N3O3 | 1155773-15-1 | Details |
| TC-Mps1-12 | C17H20N6O | 1206170-62-8 | Details |
| RMM-46；RMM 46;RMM46 | C24H26N4O5 | 1307896-46-3 | Details |
| Perfluoro(1,3-dimethylcyclohexane)；Cyclohexane, decafluoro-1,3-bis(trifluoromethyl)-;Cyclohexane, perfluoro-1,3-dimethyl-;Hexadecafluoro-1,3-dimethylcyclohexane | C8F16 | 335-27-3 | Details |
| LDN-209929 2HCl；LDN-209929 dihydrochloride;LDN209929 2HCl;LDN209929 dihydrochloride;LDN 209929 2HCl;LDN 209929 dihydrochloride | C17H17ClN2OS | 1233355-57-1 | Details |
| GSK317354A；GSK 317354A;GSK-317354A | C25H18F4N6O | 874119-13-8 | Details |
| FR-193879；FR193879;FR 193879 | C20H18N4O5S3 | 194928-82-0 | Details |
| JNJ-17156516；JNJ 17156516;JNJ17156516 | C26H22Cl2N2O3 | 649551-06-4 | Details |
| NS-2359 free base；NS-2359;GSK372475;NS 2359;GSK 372475;NS2359;GSK-372475 | C16H21Cl2NO | 195875-68-4 | Details |
| JNJ-26146900；JNJ26146900;JNJ 26146900 | C15H15F3N2O3S | 868691-50-3 | Details |
| JNJ-19567470；JNJ 19567470;JNJ19567470 | C22H27BrN4O | 724471-26-5 | Details |
| Tyk2-IN-8 | C20H17N9 | 2127109-84-4 | Details |
| Methotrexate monohydrate；Methotrexate hydrate | C20H22N8O5 | 6745-93-3 | Details |
| Dexamethasone phosphate；Hexadrol phosphate;EGP437;Neodecadron;EGP 437;EGP-437 | C22H30FO8P | 312-93-6 | Details |
| Anecortave；AL 4940;AL-4940;AL4940 | C21H28O4 | 10184-70-0 | Details |
| Fascaplysin chloride；NSC-622398;Fascaplysin;NSC 622398;NSC622398 | C18H11ClN2O | 114719-57-2 | Details |
| MSX-3；MSX 3;MSX3 | C21H21N4O7P.2Na | 261717-23-1 | Details |
| NIDA 41020 | C23H24Cl2N4O2 | 502486-89-7 | Details |
| Ro 41-0960；Ro-41-0960;Ro41-0960 | C13H8FNO5 | 125628-97-9 | Details |
| LY 165163；LY-165,163;LY165,163;LY 165,163 | C19H22F3N3 | 1814-64-8 | Details |
| 2-TEDC | C16H13NO4S | 132465-10-2 | Details |
| Diazaborine；SA-84474;Diazaborine compound 2b18;Pkf 84.474;Pkf 84474;Pkf-84474 | C14H13BN2O3S | 22959-81-5 | Details |
| Tanomastat；BAY 12-9566 | C23H19ClO3S | 179545-77-8 | Details |
| Salvinorin A | C23H28O8 | 83729-01-5 | Details |
| Ampreloxetine；TD-9855;TD 9855;TD9855 | C18H18F3NO | 1227056-84-9 | Details |
| Satavaptan fumarate；SR121463A;SR-121463 A;SR-121463A;SR 121463 A | C37H49N3O12S | 185913-79-5 | Details |
| Alaproclate, (S)-；(-)-Alaproclate;S-(-)-Alaproclate | C13H18ClNO2 | 66171-75-3 | Details |
| PR5-LL-CM01 | C23H27N7 | 1005307-86-7 | Details |
| Pentachloropseudilin；PClP | C10H4Cl5NO | 69640-38-6 | Details |
| SMP-797 HCl；SMP-797;SMP 797;SMP797 | C34H44ClN5O4 | 259224-95-8 | Details |
| Sabizabulin；VERU-111;ABI-231 | C21H19N3O4 | 1332881-26-1 | Details |
| MARK4 inhibitor 1 | C20H18N6O3 | 2271081-58-2 | Details |
| Product Total： Product Page： | ||||
| 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 | ||||